(Q38288128)

1 September 2017

title

Characterization of heparan sulfate oligosaccharides that bind to hepatocyte growth factor (English)

1 reference

1 September 2017

1 reference

Ashikari S

1

1 reference

1 September 2017

Habuchi H

series ordinal

2

1 reference

1 September 2017

Kimata K

series ordinal

3

1 reference

1 September 2017

language of work or name

English

0 references

publication date

1 December 1995

1 reference

Journal of Biological Chemistry

1 September 2017

published in

1 reference

1 September 2017

volume

270

1 reference

1 September 2017

issue

49

1 reference

1 September 2017

page(s)

29586-29593

1 reference

Proteoglycans: structures and interactions

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Heparan sulphate: functional role as a modulator of fibroblast growth factor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

The heparin-binding (fibroblast) growth factor family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Molecular cloning and expression of human hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Identity of a tumor cytotoxic factor from human fibroblasts and hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Scatter factor induces blood vessel formation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Expression of c‐met proto‐oncogene in COS cells induces the signal transducing high‐affinity receptor for hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Heparin-hepatocyte growth factor complex with low plasma clearance and retained hepatocyte proliferating activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Purification and partial characterization of the major cell-associated heparan sulphate proteoglycan of rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Characterization of a novel heparan sulfate proteoglycan found in the extracellular matrix of liver sinusoids and basement membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Functional characterization of human hepatocyte growth factor mutants obtained by deletion of structural domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Tumor cytotoxic factor/hepatocyte growth factor from human fibroblasts: cloning of its cDNA, purification and characterization of recombinant protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Smooth muscle releases an epithelial cell scatter factor which binds to heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Formation of anhydrosugars in the chemical depolymerization of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

Analysis of unsaturated disaccharides from glycosaminoglycuronan by high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.49.29586

21 January 2018

Identifiers

DOI

10.1074/JBC.270.49.29586

1 reference

1 September 2017

1 reference